产品货号：
JN1763
中文名称：
重组人血管紧张素原(AGT)(Serpin A8)
英文名称：
Recombinant Human Angiotensinogen
产品规格：
10μg|50μg|500μg|1mg
发货周期：
1～3天
产品价格：
询价
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Asp34-Ala485在C端含有His标签。
AGT质量控制：＞95%(还原性SDS-PAGE)
AGT制剂：液体
AGT保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。
关于AGT：
Angiotensinogen is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Genetic variations in Angiotensinogen are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in the encoding gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.
相关搜索：重组人血管紧张素原(AGT)(Serpin A8)，Recombinant Human Angiotensinogen
AGT质量控制：＞95%(还原性SDS-PAGE)
AGT制剂：液体
AGT保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。
关于AGT：
Angiotensinogen is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Genetic variations in Angiotensinogen are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in the encoding gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.
相关搜索：重组人血管紧张素原(AGT)(Serpin A8)，Recombinant Human Angiotensinogen